Expression of hepatitis B surface antigen gene in yeast
- PMID: 6337369
- PMCID: PMC393297
- DOI: 10.1073/pnas.80.1.1
Expression of hepatitis B surface antigen gene in yeast
Abstract
The DNA sequence coding for hepatitis B virus surface antigen (HBsAg) was placed under control of the repressible acid phosphatase promoter of the yeast Saccharomyces cerevisiae in a plasmid capable of autonomous replication in both yeast and Escherichia coli. Yeast transformed by this plasmid synthesized up to 5 X 10(5) molecules per cell of immunologically active HBsAg polypeptide in phosphate-free medium. The HBsAg polypeptides produced in the yeast cells were assembled into 20- to 22-nm spherical or oval particles and were immunogenic.
Similar articles
-
[Expression of the HBsAg gene of the hepatitis B virus under the control of the promoter region of gene PH05 in yeast cells].Vopr Virusol. 1985 Sep-Oct;30(5):558-61. Vopr Virusol. 1985. PMID: 3907141 Russian.
-
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.Nature. 1982 Jul 22;298(5872):347-50. doi: 10.1038/298347a0. Nature. 1982. PMID: 7045698
-
Characteristics of hepatitis B surface antigen produced in yeast.Biochem Biophys Res Commun. 1985 Aug 30;131(1):160-6. doi: 10.1016/0006-291x(85)91784-x. Biochem Biophys Res Commun. 1985. PMID: 3899110
-
Construction and characterization of a Saccharomyces cerevisiae strain (RIT4376) expressing hepatitis B surface antigen.Postgrad Med J. 1987;63 Suppl 2:65-70. Postgrad Med J. 1987. PMID: 3317360
-
[Production of hepatitis B vaccine by applying genetic engineering technology].Nihon Rinsho. 1983 May;41(5):1120-34. Nihon Rinsho. 1983. PMID: 6355559 Review. Japanese. No abstract available.
Cited by
-
Phage display creates innovative applications to combat hepatitis B virus.World J Gastroenterol. 2014 Sep 7;20(33):11650-70. doi: 10.3748/wjg.v20.i33.11650. World J Gastroenterol. 2014. PMID: 25206271 Free PMC article. Review.
-
Single lysophosphatidylcholine components exhibit adjuvant activities in vitro and in vivo.Clin Vaccine Immunol. 2010 Mar;17(3):429-38. doi: 10.1128/CVI.00420-09. Epub 2010 Jan 13. Clin Vaccine Immunol. 2010. PMID: 20071492 Free PMC article.
-
Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens.Mol Ther. 2022 May 4;30(5):1822-1849. doi: 10.1016/j.ymthe.2022.01.034. Epub 2022 Jan 31. Mol Ther. 2022. PMID: 35092844 Free PMC article. Review.
-
Analysis of human T-cell antigen receptor variable beta gene usage following vaccination with recombinant HBsAg.Dig Dis Sci. 1998 Apr;43(4):880-6. doi: 10.1023/a:1018846921408. Dig Dis Sci. 1998. PMID: 9558047
-
Bacterial identification using nitrocellulose blotting technique that incorporates ELISA to bacterial surface antigen.J Clin Pathol. 1987 Feb;40(2):239-41. doi: 10.1136/jcp.40.2.239. J Clin Pathol. 1987. PMID: 3546399 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources